UniProtKB/Swiss-Prot O60934: Variant p.Leu150Phe

Nibrin
Gene: NBN
Chromosomal location: 8q21-q24
Variant information

Variant position:  150
The position of the amino-acid change on the UniProtKB canonical protein sequence.

Type of variant:  Disease [Disclaimer]
The variants are classified into three categories: Disease, Polymorphism and Unclassified.
  • Disease: Variants have been found in patients and disease-association is reported in literature. However, this classification is not a definitive assessment of variant pathogenicity.
  • Polymorphism: No disease-association has been reported.
  • Unclassified: Variants have been found in patients but disease-association remains unclear.

Residue change:  From Leucine (L) to Phenylalanine (F) at position 150 (L150F, p.Leu150Phe).
Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.

Physico-chemical properties:  Change from medium size and hydrophobic (L) to large size and aromatic (F)
The physico-chemical property of the reference and variant residues and the change implicated.

BLOSUM score:  0
The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:
  • Lowest score: -4 (low probability of substitution).
  • Highest score: 11 (high probability of substitution).
More information can be found on the following page

Involvement in disease:  Breast cancer (BC) [MIM:114480]: A common malignancy originating from breast epithelial tissue. Breast neoplasms can be distinguished by their histologic pattern. Invasive ductal carcinoma is by far the most common type. Breast cancer is etiologically and genetically heterogeneous. Important genetic factors have been indicated by familial occurrence and bilateral involvement. Mutations at more than one locus can be involved in different families or even in the same case. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.
The name and a short description of the disease associated with the variant. For more information about the disease, the user can refer to OMIM, following the link provided after the disease acronym.

Variant description:  In BC.
Any additional useful information about the variant.



Sequence information

Variant position:  150
The position of the amino-acid change on the UniProtKB canonical protein sequence.

Protein sequence length:  754
The length of the canonical sequence.

Location on the sequence:   QAILQLGGFTVNNWTEECTH  L VMVSVKVTIKTICALICGRP
The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.

Residue conservation: 
The multiple alignment of the region surrounding the variant against various orthologous sequences.

Human                         QAILQLGGFTVNNWTEECTHLVMVSVKVTIKTICALICGRP

Mouse                         QAILQLGGLTANNWTEECTHLVMSAVKVTIKTICALICGRP

Rat                           QAILQLGGLTANSWTEECTHLAMSSVKVTIKTICALICGRP

Chicken                       EAIQQLGGLVVNEWTKECTHLIMESVKVTVKTICALICGRP

Zebrafish                     QDIRSVGGRLVSSWTSDCTHLVMPTVKVTIKTICALLCCRP

Sequence annotation in neighborhood:  
The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:
  • Type: the type of sequence feature.
  • Positions: endpoints of the sequence feature.
  • Description: contains additional information about the feature.

TypePositionsDescription
Chain 1 – 754 Nibrin
Domain 105 – 181 BRCT
Region 111 – 328 Mediates interaction with SP100


Literature citations

Mutation screening of Mre11 complex genes: indication of RAD50 involvement in breast and ovarian cancer susceptibility.
Heikkinen K.; Karppinen S.-M.; Soini Y.; Maekinen M.; Winqvist R.;
J. Med. Genet. 40:E131-E131(2003)
Cited for: VARIANT BC PHE-150; VARIANTS GLN-185 AND ILE-574;

Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.